Induction of the Gαq signaling cascade by the human immunodeficiency virus envelope is required for virus entry

Journal of Virology

Volumn 82, Issue 18, 2008, Pages 9191-9205

  Harmon, Brooke ^a   Ratner, Lee ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8069 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 3 [8 [(DIMETHYLAMINO)METHYL] 6,7,8,9 TETRAHYDROPYRIDO[1,2 A]INDOL 10 YL] 4 (1 METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE; CALPHOSTIN C; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; DANTROLENE; FARNESYLTHIOSALICYLIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHOLIPASE C; RAC1 PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS ENVELOPE PROTEIN; RAC1 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL FUSION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRUS ENTRY; VIRUS ENVELOPE; WESTERN BLOTTING; ANIMAL; CELL LINE; DRUG EFFECT; GENETICS; HELA CELL; MEMBRANE FUSION; METABOLISM; PATHOGENICITY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMALS; CELL LINE; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GTP-BINDING PROTEIN ALPHA SUBUNITS, GQ-G11; HELA CELLS; HIV-1; HUMANS; MEMBRANE FUSION; RAC1 GTP-BINDING PROTEIN; RECEPTORS, CCR5; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES; VIRUS INTERNALIZATION;

EID: 50949123789     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00424-08     Document Type: Article

References (60)

1. Alfano, M., and G. Poli. 2005. Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Mol. Immunol. 42:161-182.
2. Alkhatib, G., S. S. Ahuja, D. Light, S. Mummidi, E. A. Berger, and S. K. Ahuja. 1997. CC chemokine receptor 5-mediated signaling and HIV-1 coreceptor activity share common structural determinants. Critical residues in the third extracellular loop support HIV-1 fusion. J. Biol. Chem. 272:19771-19776.
3. Amara, A., A. Vidy, G. Boulla, K. Mollier, J. Garcia-Perez, J. Alcami, C. Blanpain, M. Parmentier, J.-L. Virelizier, P. Charneau, and F. Arenzana-Seisdedos. 2003. G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type 1 isolates. J. Virol. 77:2550-2558.
4. Amella, C.-A., B. Sherry, D. H. Shepp, and H. Schmidtmayerova. 2005. Macrophage inflammatory protein la inhibits postentry steps of human immunodeficiency virus type 1 infection via suppression of intracellular cyclic AMP. J. Virol. 79:5625-5631.
5. Arai, H., and I. Charo. 1996. Differential regulation of G-protein-mediated signaling by chemokine receptors. J. Biol. Chem. 271:21814-21819.
6. Atchison, R. E., J. Gosling, F. S. Montelaro, C. Franci, L. Diglio, I. F. Charo, and M. A. Goldsmith. 1996. Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science 274:1924-1926.
7. Barkan, B., S. Starinsky, E. Friedman, R. Stein, and Y. Kloog. 2006. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1. Clin. Cancer Res. 12:5533-5542.
8. Beer, C., D. S. Andersen, A. Rojek, and L. Pedersen. 2005. Caveola-dependent endocytic entry of amphotropic murine leukemia virus. J. Virol. 79:10776-10787.
9. Björndal, A., H. Deng, M. Janssen, J. R. Fiore, C. Colognesi, A. Karlsson, J. Albert, G. Scarlatti, D. R. Liftman, and E. M. Fenyö. 1997. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:7478-7487.
10. Blauket, A., I. Ivankovic-Dikic, E. Gronroos, F. Dolfi, G. Tokiwa, K. Vuori, and I. Dikic. 1999. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J. Biol. Chem. 274:14893-14901.
11. Borthakur, G., F. Ravandi, S. O'Brien, B. Williams, and F. Giles. 2007. Phase I study of s-trans, trans-farnesylthiosalicylic acid (FTS), a novel oral Ras inhibitor in patients with refractory hematologic malignancies. J. Clin. Oncol. 25:7071.
12. Brady, A. E., and E. Limbird. 2002. G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction. Cell. Signal. 14:297-309.
13. Burridge, K., and K. Wennerberg. 2004. Rho and Rac take center stage. Cell 116:167-179.
14. Cavrois, M., C. D. Noronha, and W. C. Greene. 2002. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat. Biotechnol. 20:1151-1154.
15. Cicala, C., J. Arthos, M. Ruiz, M. Vaccarezza, A. Rubbert, A. Riva, K. Wildt, O. Cohen, and A. S. Fauci. 1999. Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. J. Immunol. 163:420-426.
16. Connolly, B. A., J. Rice, L. A. Feig, and R. J. Buchsbaum. 2005. Tiam1-IRSp53 complex formation directs specificity of Rac-mediated actin cytoskeleton regulation. Mol. Cell. Biol. 25:4602-4614.
17. Connor, R. I., K. E. Sheridan, D. Ceradini, S. Choe, and N. R. Landau. 1997. Change in coreceptor use correlates with disease progression in HIV-infected individuals. J. Exp. Med. 185:621-628.
18. Davis, C. B., I. Dikic, D. Unutmaz, C. M. Hill, J. Arthos, M. A. Siani, D. A. Thompson, J. Schlessinger, and D. R. Littman. 1997. Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5. J. Exp. Med. 186:1793-1798.
19. DelCorno, M., Q.-H. Liu, D. Schols, E. deClercq, S. Gessani, B. D. Freedman, and R. G. Collman. 2001. HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent pertussis toxin-insensitive chemokine receptor signaling. Blood 98:2909-2916.
20. delReal, G., S. Jimenez-Baranda, E. Mira, R. A. Lacalle, P. Lucas, C. Gomez-Mouton, M. Alegret, J. M. Pena, M. Rodriguez-Zapata, M. Alvarez-Mon, C. A. Martinez, and S. Manes. 2004. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200:541-547.
21. Derdeyn, C. A., J. M. Decker, J. N. Sfakianos, X. Wu, W. A. O'Brien, L. Ratner, J. C. Kappes, G. M. Shaw, and E. Hunter. 2000. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74:8358-8367.
22. Eitzen, G. 2003. Actin remodeling to facilitate membrane fusion. Biochim. Biophys. Acta 1641:175-181.
23. Farzan, M., H. Choe, K. A. Martin, Y. Sun, M. Sidelko, C. R. Mackay, N. P. Gerard, J. Sodroski, and C. Gerard. 1997. HIV-1 entry and macrophage inflammatory protein-1beta-mediated signaling are independent functions of the chemokine receptor CCR5. J. Biol. Chem. 272:6854-6857.
24. Gallo, S. A., C. M. Finnegan, M. Viard, Y. Raviv, A. Dimitrov, S. S. Rawat, A. Puri, S. Durell, and R. Blumenthal. 2003. The HIV Env-mediated fusion reaction. Biochim. Biophys. Acta 1614:36-50.
25. Gosling, J., F. S. Monteclaro, R. E. Atchison, H. Arai, C.-L. Tsou, M. A. Goldsmith, and I. F. Charo. 1997. Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc. Natl. Acad. Sci. USA 94:5061-5066.
26. Graziani-Bowering, G. M., L. G. Filion, P. Thibault, and M. Kozlowski. 2002. CD4 is active as a signaling molecule on the human monocytic cell line THP-1. Exp. Cell Res. 279:141-152.
27. Hermans, E. 2003. Biochemical and pharmacological contra of the multiplicity of coupling at G-protein-coupled receptors. Pharmacol. Ther. 99:25-44.
28. Heuss, C., and U. Gerber. 2000. G-protein-independen! signaling by G-protein-coupled receptors. Trends Neurosci. 23:469-475.
29. Iyengar, K., J. E. K. Hildreth, and D. H. Schwartz. 1998 Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J. Virol. 72:5251-5255.
30. Jan, C.-R., C.-M. Ho, S.-N. Wu, and C.-J. Tseng. 1998. The phospholipase C inhibitor U73122 increases cytosolic calcium in MDCK cells by activating calcium influx and releasing stored calcium. Life Sci. 63:895-908.
31. Jimenez-Baranda, S., C. Gomez-Mouton, A. Rojas, L. Martinez-Prats, E. Mira, R. AnaLacalle, A. Valencia, D. S. Dimitrov, A. Viola, R. Delgado, A. C. Martinez, and S. Manes. 2007. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat. Cell Biol. 9:838-846.
32. Kanmogne, G. D., K. Schall, J. Leibhart, B. Knipe, H. E. Gendelman, and Y. Persidsky. 2006. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J. Cereb. Blood Flow Metab. 27:123-134.
33. Khwaja, A., C. C. Sharpe, M. Noor, Y. Kloog, and B. M. Hendry. 2006. The role of geranylgeranylated proteins in human mesangial cell proliferation. Kidney Int. 70:1296-1304.
34. Kloog, Y., and D. A. Cox. 2004. Prenyl-binding domains: potential targets for Ras inhibitors and anti-cancer drugs. Semin. Cancer Biol. 14:253-261.
35. Lambert, J. M., Q. T. Lambert, G. W. Reuther, A. Malliri, D. P. Sidereovski, J. Sondek, J. G. Collard, and C. J. Der. 2002. Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism. Nat. Cell Biol. 4:621-625.
36. Lee, C., Q.-H. Liu, B. Tomkowicz, Y. Yi, B. D. Freedman, and R. G. Collman. 2003. Macrophage activation through CCR5- and CXCR4-mediated gp120-elicited signaling pathways. J. Leukoc. Biol. 74:676-682.
37. Liu, Q.-H., D. A. Williams, C. McManus, F. Baribaud, R. W. Doms, D. Schols, E. DeClercq, M. I. Kotlikoff, R. G. Collman, and B. D. Freedman. 2000. HIV-2 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation. Proc. Natl. Acad. Sci. USA 97:4832-4837.
38. Mackay, H. J., and C. J. Twelves. 2007. Targeting the protein kinase C family: are we there yet? Nat. Rev. Cancer 27:554-562.
39. Maddon, P. J., J. S. McDougal, P. R. Clapham, A. G. Dalgleish, S. Jamal, R. A. Weiss, and R. Axel. 1988. HIV infection does not require endocytosis of its receptor, CD4. Cell 54:865-867.
40. Maghazachi, A. A., and A. Al-Aoukaty. 1998. Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer. FASEB J. 12:913-924.
41. Masci, A. M., M. Galgani, S. Cassano, S. DeSimone, A. Gallo, V. DeRosa, S. Zappacosta, and L. Racioppi. 2003. HIV-1 gp120 induces inergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling. J. Leukoc. Biol. 74:1117-1124.
42. Mertens, A. E., R. C. Rooberes, and J. G. Collard. 2003. Regulation of Tiam1-Rac signaling. FEBS Lett. 546:11-16.
43. Murasawa, S., H. Matsubara, Y. Mori, H. Masaki, Y. Isutsumi, Y. Shibasaki, I. Kitabayashi, Y. Tanaka, S. Fujiyama, Y. Koyama, A. Fujiyama, S. Iba, and T. Iwasaka. 2000. Angiotensin II initiates tyrosine kinase Pyk2-dependent signalings leading to activation of Rac1-mediated c-Jun NH2-terminal kinase. J. Biol. Chem. 275:26856-26863.
44. Nussbaum, O., C. C. Broder, and E. A. Berger. 1994. Fusogenic mechanisms of envcloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:5411-5422.
45. Oppermann, M. 2004. Chemokine receptor CCR5: insights into structure, function, and regulation. Cell. Signal. 16:1201-1210.
46. Pontow, S., B. Harmon, N. Campbell, and L. Ratner. 2007. Antiviral activity of a Rac-GEF inhibitor characterizes with a sensitive HIV/SIV fusion assay. Virology 368:1-6.
47. Pontow, S., and L. Ratner. 2001. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors. J. Virol. 75:11503-11514.
48. Pontow, S. E., N. V. Heyden, S. Wei, and L. Ratner. 2004. Actin cytoskeletal reorganizations and coreceptor-mediated activation of Rac during human immunodeficiency virus-induced cell fusion. J. Virol. 78:7138-7147.
49. Popik, W., J. E. Hesselgesser, and P. M. Pitha. 1998. Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway. J. Virol. 72:6406-6413.
50. Popik, W., and P. M. Pitha. 1998. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor. Virology 252:210-217.
51. Popik, W., and P. M. Pitha. 2000. Exploitation of cellular signaling of HIV-1: unwelcome guests with master keys that signal their entry. Virology 276:1-6.
52. Price, M. O., S. J. Atkinson, U. G. Knaus, and M. C. Dinauer. 2002. Rac activation induces NAPDH oxidase activity in transgenic COSphox cells, and the level of superoxide production is exchange factor-dependent. J. Biol. Chem. 277:19220-19228.
53. Stantchev, T. S., and C. C. Broder. 2001. Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors. Cytokine Growth Factor Rev. 19:219-243.
54. Stantchev, T. S., I. Markovic, W. G. Telford, K. A. Clouse, and C. C. Broder. 2007. The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages. Virus Res. 123:178-189.
55. Suh, B.-C., and B. Hille. 2002. Recovery from muscarinic modulation of M current channels requires phosphatidylinositol 4,5-bisphosphate synthesis. Neuron 35:507-520.
56. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, and F. Loriolle. 1991. The bisin-dolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771-15781.
57. Treiman, M., C. Caspersen, and S. B. Christensen. 1998. A tool coming of age: thapsigargin as an inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Trends Pharmacol. Sci. 19:131-135.
58. Wei, X., J. M. Decker, H. Liu, Z. Zhang, R. B. Arani, J. M. Kilby, M. S. Saag, X. Wu, G. M. Shaw, and J. C. Kappes. 2002. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46:1896-1905.
59. Wu, D., H. Jiang, A. Katz, and M. I. Simon. 1993. Identification of critical regions on phospholipase C-beta 1 required for activation by G-proteins. J. Biol. Chem. 268:3704-3709.
60. Zhou, K., Y. Wang, J. L. Gorski, N. Nomura, J. Collard, and G. M. Bokoch. 1998. Guanine nucleotide exchange factors regulate specificity of downstream signaling from Rac and Cdc42. J. Biol. Chem. 273:16782-16786.